• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

CD82 Rekombinanter Antikörper

CD82 Rekombinant Antikörper für IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

241765E10

Kat-Nr. : 84617-3-PBS

Synonyme

CD82, KAI1, 241765E10, CD 82, CD82,KAI1, IA4

Filter:
  • Immunofluorescence (IF) / fluorescent staining of A549 cells using CD82 Recombinant antibody (84617-3-RR)

    IF Staining of A549 using 84617-3-RR (same clone as 84617-3-PBS)

    Immunofluorescent analysis of (4% PFA) fixed A549 cells using CD82 antibody (84617-3-RR, Clone: 241765E10 ) at dilution of 1:400 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2). This data was developed using the same antibody clone with 84617-3-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

84617-3-PBS bindet in IF/ICC, Indirect ELISA CD82 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen CD82 fusion protein Eg1749
Vollständiger Name CD82 molecule
Berechnetes Molekulargewicht30 kDa
GenBank-ZugangsnummerNM_002231.4
Gene symbol CD82
Gene ID (NCBI) 3732
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CD82 is a membrane glycoprotein and belongs to the tetraspanin superfamily, many of which are implicated in the regulation of cell motility, morphology, fusion, signaling, fertilization, and differentiation. CD82 was originally identified as a suppressor of metastasis located on human chromosome 11p11.2 in prostate carcinoma. The majority of evidence indicates that CD82 expression is downregulated or abolished in a variety of malignant tumors. CD82 is present at high levels in human monocyte and macrophage lineages and in various epithelial cells in the prostate, lung, pancreas and many other tissues. In epithelial cells, CD82 is implicated in diverse biological processes such as cell adhesion, migration, apoptosis and morphogenesis.